In a filing, Maravai LifeSciences Holdings Inc revealed its Director DeFord John A acquired Company’s shares for reported $0.1 million on Nov 12 ’24. In the deal valued at $5.75 per share,17,500 shares were bought. As a result of this transaction, DeFord John A now holds 70,046 shares worth roughly $0.31 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, HULL CARL bought 175,000 shares, generating $987,000 in total proceeds. Upon buying the shares at $5.64, the insider now owns 175,000 shares.
Before that, GTCR INVESTMENT XI LLC sold 9,940,974 shares. Maravai LifeSciences Holdings Inc shares valued at $97,570,660 were divested by the Director at a price of $9.81 per share. As a result of the transaction, GTCR INVESTMENT XI LLC now holds 20,150,005 shares, worth roughly $89.06 million.
Wolfe Research initiated its Maravai LifeSciences Holdings Inc [MRVI] rating to a Peer perform in a research note published recently. A number of analysts have revised their coverage, including William Blair’s analysts, who decreased its forecast for the stock in early November from “an Outperform” to “a Mkt perform”. Wells Fargo began covering MRVI with “an Overweight” recommendation on August 28, 2024. Morgan Stanley revised its rating on August 13, 2024. It rated MRVI as “an Equal-weight” which previously was an “an Overweight”.
Price Performance Review of MRVI
On Friday, Maravai LifeSciences Holdings Inc [NASDAQ:MRVI] saw its stock fall -15.00% to $4.42. Over the last five days, the stock has lost -12.91%. Maravai LifeSciences Holdings Inc shares have fallen nearly -32.52% since the year began. Nevertheless, the stocks have fallen -14.84% over the past one year. While a 52-week high of $11.56 was reached on 05/17/24, a 52-week low of $4.68 was recorded on 11/15/24. SMA at 50 days reached $7.76, while 200 days put it at $8.10.
Levels Of Support And Resistance For MRVI Stock
The 24-hour chart illustrates a support level at 4.09, which if violated will result in even more drops to 3.75. On the upside, there is a resistance level at 5.06. A further resistance level may holdings at 5.70. The Relative Strength Index (RSI) on the 14-day chart is 26.26, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.55, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.23%. Stochastics %K at 13.46% indicates the stock is a buying.
How much short interest is there in Maravai LifeSciences Holdings Inc?
A steep rise in short interest was recorded in Maravai LifeSciences Holdings Inc stocks on 2024-10-31, dropping by -1.0 million shares to a total of 8.22 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 9.22 million shares. There was a decline of -12.17%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 10, 2024 when Craig Hallum began covering the stock and recommended ‘”a Buy”‘ rating along with a $15 price target.
